Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.700
-0.220 (-7.53%)
At close: Apr 28, 2026, 4:00 PM EDT
2.720
+0.020 (0.74%)
After-hours: Apr 28, 2026, 7:00 PM EDT
BDTX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 70 | - | - | - | - | |
| Gross Profit | 70 | - | - | - | - | |
| Selling, General & Admin | 16.57 | 27.47 | 27.11 | 28.39 | 30.04 | |
| Research & Development | 33.56 | 51.31 | 59.35 | 64.44 | 96.83 | |
| Operating Expenses | 50.13 | 78.78 | 86.46 | 92.83 | 126.87 | |
| Operating Income | 19.87 | -78.78 | -86.46 | -92.83 | -126.87 | |
| Interest & Investment Income | 4.06 | 2.18 | 1.92 | 2.03 | 3.46 | |
| Earnings From Equity Investments | - | - | - | -2.25 | - | |
| Currency Exchange Gain (Loss) | - | - | - | - | -0 | |
| Other Non Operating Income (Expenses) | 4.51 | 3.14 | 0.92 | 0.18 | - | |
| EBT Excluding Unusual Items | 28.44 | -73.46 | -83.62 | -92.87 | -123.41 | |
| Gain (Loss) on Sale of Investments | 1.28 | 3.78 | 1.17 | -0.54 | -2.19 | |
| Gain (Loss) on Sale of Assets | - | - | - | 2.23 | - | |
| Asset Writedown | -7.35 | - | - | - | - | |
| Pretax Income | 22.37 | -69.68 | -82.44 | -91.17 | -125.6 | |
| Net Income | 22.37 | -69.68 | -82.44 | -91.17 | -125.6 | |
| Net Income to Common | 22.37 | -69.68 | -82.44 | -91.17 | -125.6 | |
| Shares Outstanding (Basic) | 57 | 55 | 44 | 36 | 36 | |
| Shares Outstanding (Diluted) | 58 | 55 | 44 | 36 | 36 | |
| Shares Change (YoY) | 4.61% | 25.19% | 21.00% | 0.38% | 9.97% | |
| EPS (Basic) | 0.39 | -1.27 | -1.88 | -2.51 | -3.47 | |
| EPS (Diluted) | 0.39 | -1.27 | -1.88 | -2.51 | -3.47 | |
| Free Cash Flow | 29.61 | -62.3 | -66.75 | -85.27 | -102.86 | |
| Free Cash Flow Per Share | 0.51 | -1.13 | -1.52 | -2.35 | -2.84 | |
| Gross Margin | 100.00% | - | - | - | - | |
| Operating Margin | 28.39% | - | - | - | - | |
| Profit Margin | 31.95% | - | - | - | - | |
| Free Cash Flow Margin | 42.31% | - | - | - | - | |
| EBITDA | 20.2 | -78.44 | -86.02 | -92.32 | -126.67 | |
| EBITDA Margin | 28.85% | - | - | - | - | |
| D&A For EBITDA | 0.33 | 0.34 | 0.44 | 0.51 | 0.21 | |
| EBIT | 19.87 | -78.78 | -86.46 | -92.83 | -126.87 | |
| EBIT Margin | 28.39% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.